LeMaitre: Further Upsides Supported By Longer Competitive Advantage Period

1 IF D H HT T 100 - 100 1 i T 1 Pgiam/iStock via Getty Images Following my last report on LeMaitre Vascular, Inc. (NASDAQ:LMAT) in August FY'23, shares have rallied another 45% into the green, along with 1) increased dividends and 2) improving fundamentals. Back then, I valued the stock at ~$85/share, roughly where it trades today. LMAT is a long-term compounder with mouth-watering economics in my view. Management's efforts have produced a 27% CAGR in market value and 18% CAGR in dividend growth since 2011 ...